EXPRESSION OF CONCERN: Clinical significance and safety profile of antibody-drug conjugates in malignancies of the female reproductive system
Abstract
The editors express concern regarding the following review article: Uzdenova D.M., Timofeeva E.A., Isaev D.M., Mestoeva Z.B., Evsikova E.R., Kuznetsova A.A., Zabelin N.V., Kovalenko Yu.V., Kuznetsov D.S., Bembeeva A.E., Monid K.A., Koleukho A.V., Gil U.M. Clinical significance and safety profile of antibody-drug conjugates in malignancies of the female reproductive system. Obstetrics, Gynecology and Reproduction. 2026;20(4):802–819. (In Russ.). https://doi.org/10.17749/2313-7347/ob.gyn.rep.2026.769. The reason was doubts about compliance with publication ethics, concerning the authorship and documents authenticity. Currently the editorial board is conducting a revision in accordance with the Committee on Publication Ethics (COPE) recommendations. Until the examination is completed, readers are recommended to interpret the contents of this review taking these circumstances into account.
Fields of Study & Subjects
Ovarian cancer diagnosis and treatment
Advanced Breast Cancer Therapies
Cancer Risks and Factors
Publication details
- Journal / source
- Obstetrics Gynecology and Reproduction
- Publisher
- IRBIS
- Volume
- 20
- Issue
- 4
- Pages
- 820–822
- Publication date
- 14 September 2026